Pomalyst plus Velcade with dexamethasone improves survival outcomes for patients with relapsed/refractory multiple myeloma, according to a phase 3 trial. The treatment combination of Pomalyst ...
Cancer researchers are a stubborn lot. They know the numbers: more than 16,000 people die from cancer every day. They know the enemy: an insidious disease that ravages virtually every organ in the ...
MALVERN, Pa.--(BUSINESS WIRE)--Researchers at the Dana-Farber Cancer Institute and Progenra, Inc. announce the publication of a research article entitled “A Small Molecule Inhibitor of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback